Article
Difference in transducin-like enhancer of split 1 protein expression between basal cell adenomas and basal cell adenocarcinomas - an immunohistochemical study.
Diagnostic pathology - 27 Jul 2018
Oyama Yuzo, Nishida Haruto, Kusaba Takahiro, Kadowaki Hiroko, Arakane Motoki, Wada Junpei, Urabe Shogo, Hirano Takashi, Kawano Kenji, Suzuki Masashi, Yokoyama Shigeo, Daa Tsutomu
Abstract excerpt
BACKGROUND: Basal cell adenoma (BCA) and basal cell adenocarcinoma (BCAC) are benign and malignant, basaloid salivary gland neoplasms, respectively. These tumors show a dual-cell proliferation of inner luminal/ductal cells and outer abluminal/myoepithelial or basal cells. The only difference between them is defined as a malignant morphology such as invasion. Recently, the nuclear expression of β-catenin and a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.